Skip to contentP
Pulse Biosciences, Inc.
P
PLSEPulse Biosciences, Inc. Q2 2022 · 10-Q
Revenue$265.00K$265.00Kno prior Q2 2021 on file Net Income-$14.00M-$14.00MN/M vs Q2 2021 EPS Diluted-$0.44-$0.44N/M vs Q2 2021 Operating Income-$14,014,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$12,841,000N/M Margins · derivedOperating margin-5288.3%
Net margin-5281.5%
ended Jun 30, 2022 · filed Aug 10, 2022 · 41 d after period end